TWM628606U - Packaging bag of weight loss composition for periodic consumption - Google Patents
Packaging bag of weight loss composition for periodic consumption Download PDFInfo
- Publication number
- TWM628606U TWM628606U TW111200619U TW111200619U TWM628606U TW M628606 U TWM628606 U TW M628606U TW 111200619 U TW111200619 U TW 111200619U TW 111200619 U TW111200619 U TW 111200619U TW M628606 U TWM628606 U TW M628606U
- Authority
- TW
- Taiwan
- Prior art keywords
- packaging bag
- weight
- water
- swelling agent
- soluble cellulose
- Prior art date
Links
- 238000004806 packaging method and process Methods 0.000 title claims abstract description 115
- 239000000203 mixture Substances 0.000 title claims abstract description 31
- 230000000737 periodic effect Effects 0.000 title claims abstract description 25
- 230000004580 weight loss Effects 0.000 title abstract description 23
- 239000001913 cellulose Substances 0.000 claims abstract description 55
- 229920002678 cellulose Polymers 0.000 claims abstract description 55
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 47
- 230000008961 swelling Effects 0.000 claims abstract description 47
- 229920000569 Gum karaya Polymers 0.000 claims abstract description 10
- 241000934878 Sterculia Species 0.000 claims abstract description 9
- 239000000231 karaya gum Substances 0.000 claims abstract description 9
- 229940039371 karaya gum Drugs 0.000 claims abstract description 9
- 235000010494 karaya gum Nutrition 0.000 claims abstract description 9
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 8
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 8
- 230000001568 sexual effect Effects 0.000 claims abstract description 3
- 229920002562 Polyethylene Glycol 3350 Polymers 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims 1
- 239000004793 Polystyrene Substances 0.000 abstract 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 abstract 1
- 229920002223 polystyrene Polymers 0.000 abstract 1
- 238000009463 water soluble packaging Methods 0.000 abstract 1
- 208000016261 weight loss Diseases 0.000 description 22
- 238000010586 diagram Methods 0.000 description 16
- 230000000694 effects Effects 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 235000020828 fasting Nutrition 0.000 description 6
- 239000000883 anti-obesity agent Substances 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- -1 blocks Substances 0.000 description 3
- 235000021152 breakfast Nutrition 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000003642 hunger Nutrition 0.000 description 3
- 235000020829 intermittent fasting Nutrition 0.000 description 3
- 208000017701 Endocrine disease Diseases 0.000 description 2
- 241000219071 Malvaceae Species 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 229920010126 Linear Low Density Polyethylene (LLDPE) Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000012644 addition polymerization Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000011111 cardboard Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 235000021197 fiber intake Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000037219 healthy weight Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 description 1
- 229960001243 orlistat Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 238000012643 polycondensation polymerization Methods 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- UNAANXDKBXWMLN-UHFFFAOYSA-N sibutramine Chemical compound C=1C=C(Cl)C=CC=1C1(C(N(C)C)CC(C)C)CCC1 UNAANXDKBXWMLN-UHFFFAOYSA-N 0.000 description 1
- 229960004425 sibutramine Drugs 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
Images
Landscapes
- Packages (AREA)
Abstract
本創作揭露一種週期性食用之減重組合物的包裝袋,由內含有刺梧桐膠的溶脹劑包裝袋、內含有聚乙二醇的水溶性纖維素包裝袋、及將溶脹劑包裝袋與水溶性纖維素包裝袋打包為在時間週期內使用之一群體的組合件,透過本創作之週期性食用之減重組合物的包裝袋,可輔助使用者在建議時間內正確使用刺梧桐膠及聚乙二醇,以達到最佳的使用體驗及減重效果。 This creation discloses a packaging bag of a weight-reducing composition for periodic consumption, which comprises a swelling agent packaging bag containing karaya gum, a water-soluble cellulose packaging bag containing polyethylene glycol, and a swelling agent packaging bag and a water-soluble packaging bag. The sexual cellulose packaging bag is packaged as an assembly of a group to be used within a time period. Through the packaging bag of the weight-reducing composition for periodic consumption of this creation, it can assist users to correctly use karaya gum and polystyrene within the recommended time period. Glycol for the best user experience and weight loss.
Description
本創作涉及一種減重包裝袋,尤指一種可協助使用者按建議方法使用的週期性食用之減重組合物的包裝袋。 The present invention relates to a weight loss packaging bag, especially a packaging bag for the periodic consumption of weight loss composition that can be used by the user according to the suggested method.
隨著時代演進,對健康的定義也不斷的更迭,減重亦是如此,早期的減重藥係透過作用於神經中樞系統,或調控內分泌,造成降低食慾、增加排泄、提升代謝率、減少吸收等效果,以達到減重之目的;然而,服用該些藥物如西布曲明(Sibutramine)、奧利司他(Orlistat)卻也必須承受減重藥物帶來的副作用,常見像是口乾、失眠、心跳加快、血壓上升、內分泌失調,為了減重而帶給身體不小的負擔;另,許多血糖相關疾病,如糖尿病等,亦不適合服用前述藥物,因其恐會造成血糖不穩,對於患者本身具有相當的風險;由於前述減重藥的問題,使民眾漸漸對藥物減重望之卻步,故近年來則風行透過運動、飲食控制等調整自身生活習慣的方式以達到減重的目的,其中,又以間歇性斷食尤為盛行,間歇性斷食(Intermittent fasting)係指將一整天的 進食時間集中在一段時間內,或是一周內挑選幾天降低食物攝取,常見的如「168斷食」、「52斷食」,分別指一天當中進食的時間控制在8小時內,以及一周挑選2天降低攝取食物,經過實驗證實皆能有效幫助減重;然而,儘管間歇性斷食有良好的效果,但執行者在過程中必須得忍受強烈飢餓感,進而導致許多人不得不在過程中放棄;此外,些許個案由於斷食導致纖維攝取減少,而面臨排便不順利的問題;另,常見的減重藥物或食品為單一罐裝形式,在使用該些減重藥物或食品時,經常因為生活忙碌、疏忽,或使用規則繁複,使執行者無法依照建議的使用規則;據此,如何能夠有效的改善執行者的使用狀況,而能簡單的依照建議執行,並且同時降低飢餓感,又不需承受前述減重藥物的副作用,讓減重執行者能夠更順利的減少進食、斷食、甚至改善便秘的問題,以達到全方位的健康減重實為待解決的問題。 With the evolution of the times, the definition of health is constantly changing, and the same is true for weight loss. Early weight loss drugs acted on the nervous central system or controlled endocrine, resulting in decreased appetite, increased excretion, increased metabolic rate, and decreased absorption. However, taking these drugs such as Sibutramine and Orlistat also have to suffer the side effects of weight loss drugs, such as dry mouth, Insomnia, rapid heartbeat, increased blood pressure, and endocrine disorders will bring a lot of burden to the body in order to lose weight; in addition, many blood sugar-related diseases, such as diabetes, are not suitable for taking the above drugs, because they may cause blood sugar instability. The patients themselves have considerable risks; due to the aforementioned problems with weight loss drugs, people are gradually turning away from drugs for weight loss. Therefore, in recent years, it has become popular to adjust their living habits through exercise, diet control, etc. to achieve the goal of weight loss. Among them, intermittent fasting is particularly popular. Intermittent fasting refers to the The eating time is concentrated within a certain period of time, or a few days of the week are selected to reduce food intake. Common ones such as "168 fasting" and "52 fasting" refer to the control of eating time in a day within 8 hours, and the selection of one week. 2-day reduction in food intake has been experimentally proven to be effective in helping weight loss; however, despite the good results of intermittent fasting, performers must endure intense hunger during the process, which leads many to give up in the process ; In addition, some cases faced the problem of unsmooth defecation due to the reduction of fiber intake due to fasting; in addition, common weight loss medicines or foods are in the form of single cans, and when using these weight loss medicines or foods, they are often busy because of their busy lives. , negligence, or complicated usage rules, so that the executor cannot follow the suggested usage rules; according to this, how to effectively improve the executor's usage, and simply follow the recommendations, and at the same time reduce hunger without suffering The aforementioned side effects of weight loss drugs allow weight loss practitioners to reduce eating, fasting, and even improve constipation more smoothly, so as to achieve a comprehensive healthy weight loss. It is a problem to be solved.
有鑒於上述的問題,本創作人係依據多年來從事相關行業的經驗,針對減重包裝袋進行改進;緣此,本創作之主要目的在於提供一種供使用者良好體驗的週期性食用之減重組合物的包裝袋。 In view of the above problems, the creator has made improvements to the weight loss packaging bag based on years of experience in related industries; therefore, the main purpose of this creation is to provide users with a good experience of periodic consumption of weight loss. The packaging bag of the composition.
為達上述的目的,本創作之週期性食用之減重組合物的包裝袋包含有一溶脹劑包裝袋、一水溶性纖維素包裝袋、及一組合件,溶脹劑包裝袋及水溶性纖維素包裝袋分 別內含有刺梧桐膠及聚乙二醇,並透過組合件將至少一溶脹劑包裝袋及至少一水溶性纖維素包裝袋打包為在一時間週期使用的一群體;如此,使用者在使用本創作之週期性食用之減重組合物的包裝袋時,係可清楚了解每天建議的使用量及使用規則;另外,更透過溶脹劑包裝袋及水溶性纖維素包裝袋上之時間提示標示,輔助使用者具有更直覺的使用體驗。 In order to achieve the above-mentioned purpose, the packaging bag of the periodically edible weight-reducing composition of the present invention includes a swelling agent packaging bag, a water-soluble cellulose packaging bag, and an assembly, a swelling agent packaging bag and a water-soluble cellulose packaging bag. bag points It contains karaya gum and polyethylene glycol, and at least one swelling agent packaging bag and at least one water-soluble cellulose packaging bag are packaged into a group for use in a period of time through the assembly; When creating the packaging bag of the weight-loss composition for periodic consumption, you can clearly understand the daily recommended usage amount and usage rules; Users have a more intuitive experience.
為使 貴審查委員得以清楚了解本創作之目的、技術特徵及其實施後之功效,茲以下列說明搭配圖示進行說明,敬請參閱。 In order to enable your reviewers to have a clear understanding of the purpose, technical features and effects of this creation, the following descriptions and illustrations are used for illustration, please refer to.
1:週期性食用之減重組合物的包裝袋 1: Packaging bag of the weight loss composition for periodic consumption
11:溶脹劑包裝袋 11: Swelling agent packaging bag
12:水溶性纖維素包裝袋 12: Water-soluble cellulose packaging bag
13:組合件 13: Assembly
131:卡扣部 131: Buckle part
F:溶脹劑 F: swelling agent
C:水溶性纖維素 C: water-soluble cellulose
A:易撕口 A: Easy to tear
B:易撕線 B: Easy tear line
T:時間提示標示 T: Time reminder sign
12_1:水溶性纖維素包裝袋 12_1: Water-soluble cellulose packaging bag
12_2:水溶性纖維素包裝袋 12_2: Water-soluble cellulose packaging bag
12_3:水溶性纖維素包裝袋 12_3: Water-soluble cellulose packaging bag
12_4:水溶性纖維素包裝袋 12_4: Water-soluble cellulose packaging bag
圖1,為本創作之結構示意圖(一)。 Figure 1 is a schematic diagram of the structure of this creation (1).
圖2,為本創作之結構示意圖(二)。 Figure 2 is a schematic diagram (2) of the structure of this creation.
圖3,為本創作之實施示意圖(一)。 Figure 3 is a schematic diagram (1) of the implementation of this creation.
圖4,為本創作之實施示意圖(二)。 Figure 4 is a schematic diagram (2) of the implementation of this creation.
圖5,為本創作之實施示意圖(三)。 Figure 5 is a schematic diagram of the implementation of this creation (3).
圖6,為本創作之實施示意圖(四)。 Figure 6 is a schematic diagram (4) of the implementation of this creation.
圖7,為本創作之實施示意圖(五)。 Figure 7 is a schematic diagram (5) of the implementation of this creation.
圖8,為本創作之實施示意圖(六)。 Figure 8 is a schematic diagram (6) of the implementation of this creation.
圖9,為本創作之實施示意圖(七)。 Figure 9 is a schematic diagram (7) of the implementation of this creation.
圖10,為本創作之另一實施例。 FIG. 10 is another embodiment of the present invention.
圖11,為持續使用本創作之時間與體重變化的關係圖(一)。 Figure 11 is a graph showing the relationship between time and body weight changes during continuous use of this creation (1).
圖12,為持續使用本創作之時間與體重變化的關係圖(二)。 Figure 12 is a graph showing the relationship between time and weight changes during continuous use of this creation (2).
請參閱「圖1」,圖1為本創作之結構示意圖(一),如圖所示,本創作之週期性食用之減重組合物的包裝袋1係包含有一溶脹劑包裝袋11、一水溶性纖維素包裝袋12、及一組合件13;以下對各組成要件進行例示:
Please refer to "Fig. 1", Fig. 1 is a schematic structural diagram (1) of the creation. As shown in the figure, the
(1)溶脹劑包裝袋11內含有作為一溶脹劑F的刺梧桐膠(Karaya gum,sterculia gum),其由梧桐科(Sterculiaceae)蘋婆屬(Sterculia)之樹木汁液中提取而成之天然高分子溶脹劑F,刺梧桐膠於水中可大量吸收水分,並膨脹至原體積的60-100倍,其劑型可包含有粒徑3-5mm之顆粒劑、塊狀、粉劑、懸浮液、膠體等,但不以此為限。
(1) The swelling
(2)水溶性纖維素包裝袋12內含有作為一水溶性纖維素C的聚乙二醇(Polyethylene Glycol,PEG)之寡聚物,其分子量可為200-9500,更佳的,水溶性纖維素C係為PEG-3350,聚乙二醇由乙二醇縮合聚合或由環氧乙烷與水加成聚合而得,其劑型可包含有發泡錠、粉劑、錠片、膠囊、水溶液、懸浮液等,但不以此為限。
(2) The water-soluble
(3)組合件13可將至少一溶脹劑包裝袋11及至少一水溶性纖維素包裝袋12打包(package)為在一時間週期內使用的一群體(group),組合件13可例如成型為一片狀,
其由紙板、塑膠、金屬等材料組成,並可以黏貼、穿釘等方式將溶脹劑包裝袋11及水溶性纖維素包裝袋12限位於組合件13;另外,請參閱「圖2」,圖2為本創作之結構示意圖(二),組合件13更可成型有一卡扣部131,可透過卡扣部131將溶脹劑包裝袋11及水溶性纖維素包裝袋12卡固於組合件13,如此使用者係可簡單將溶脹劑包裝袋11及水溶性纖維素包裝袋12由組合件13拆卸下來,增加使用的便利性;又,組合件13亦可呈一袋狀樣態,將一時間週期內建議使用之溶脹劑包裝袋11及水溶性纖維素包裝袋12以各袋裝分別打包,以此輔助使用者正確的使用。
(3) The
(4)溶脹劑包裝袋11及水溶性纖維素包裝袋12可例如為鋁箔複合材料袋,其可由聚對苯二甲酸乙二酯(polyethylene terephthalate,PET)、鋁(Aluminium,AL)、尼龍(Nylon)、線型低密度聚乙烯(LLDPE)、聚丙烯薄膜(R-CPP)之其中一種或其組合,透過由該些材料組合之溶脹劑包裝袋11及水溶性纖維素包裝袋12,可確保袋內刺梧桐膠及聚乙二醇被良好的保存,及兼顧本創作週期性食用之減重組合物的包裝袋1運輸和儲存的便利性。
(4) The swelling
當使用者服用本創作之週期性食用之減重組合物的包裝袋後,其中,作為溶脹劑的刺梧桐膠係大量吸收水分膨脹為服用溶脹劑體積的10-100倍,而作為水溶性纖維素 的聚乙二醇亦會吸收水分膨脹,兩者係可在不需進食,及不攝取其他熱量的情況下,有效增加使用者的飽足感,又,由於並未攝取食物,係可幫助使用者能容易執行如:斷食或過午不食等飲食控制計畫;此外,由於溶脹劑及水溶性纖維素素完全不被人體代謝吸收,而會經過消化系統後排出,因此,溶脹劑及水溶性纖維素係可促進腸胃蠕動,而不會造成內分泌失調等副作用;此外,水溶性纖維素因完全溶於水並會於吸收水分後,造成輕度腹瀉效果,而溶脹劑則在大量吸收水分後與糞便結合,進而增加便量,因此,在兩者的協同作用下,係可幫助使用者能促進腸道系統運作,改善便秘、宿便的問題,進而達到減重之目的。 When the user takes the packaging bag of the periodic edible weight loss composition of the present invention, the karaya gum as a swelling agent absorbs a large amount of water and expands to 10-100 times the volume of the swelling agent, and acts as a water-soluble fiber white The polyethylene glycol will also absorb moisture and expand, both of which can effectively increase the user's sense of satiety without eating or ingesting other calories, and because they do not ingest food, they can help the user. People can easily implement diet control plans such as: fasting or not eating after noon; in addition, since swelling agents and water-soluble cellulose are not metabolized and absorbed by the human body at all, but will be excreted through the digestive system, therefore, swelling agents and water-soluble cellulose Sexual cellulose can promote gastrointestinal motility without causing side effects such as endocrine disorders; in addition, water-soluble cellulose is completely soluble in water and will cause mild diarrhea after absorbing water, while swelling agent will absorb a large amount of water. Combine with feces to increase the amount of feces. Therefore, under the synergistic effect of the two, it can help users to promote the operation of the intestinal system, improve the problems of constipation and stool, and then achieve the goal of weight loss.
請參閱「圖3」,圖3為本創作之實施示意圖(一),如圖所示,本創作之溶脹劑包裝袋11、及水溶性纖維素包裝袋12具有一易撕口A,易撕口A供使用者便於打開溶脹劑包裝袋11、及水溶性纖維素包裝袋12,其可為缺線、缺角、缺口、鋸齒狀等態樣,但不以此為限。
Please refer to "Fig. 3", Fig. 3 is a schematic diagram of the implementation of the creation (1), as shown in the figure, the swelling
請參閱「圖4」,圖4為本創作之實施示意圖(二),並搭配參閱「圖1」,如圖所示,本創作之溶脹劑包裝袋11、及水溶性纖維素包裝袋12以一易撕線B相連接,以此將溶脹劑包裝袋11、及水溶性纖維素包裝袋12相組合為一群體,供使用者便於定時定量使用,在此實例中係可將易撕線B視作為組合件13之實施例之一;此外,請參閱「圖5」,圖5
為本創作之實施示意圖(三),如圖所示,在另一實施例中,本創作之溶脹劑包裝袋11、及水溶性纖維素包裝袋12以易撕線B相連接,作為群體時,將易撕口A位置成型在易撕線B撕除的周緣,且各易撕線B僅成型有唯一的易撕口A,如此使用者在使用本創作之週期性食用之減重組合物的包裝袋1時,不僅透過組合件13可清楚在一定時間週期內(如:一天之內)必須將由組合件13打包的群體使用完畢,更可藉由前述易撕口A及易撕線B的成型位置,輔助使用者能依較好的順序將本創作之週期性食用之減重組合物的包裝袋1使用完畢。
Please refer to "Fig. 4", Fig. 4 is a schematic diagram (2) of the implementation of the creation, and also refer to "Fig. 1". As shown in the figure, the swelling
請參閱「圖6」~「圖9」所示,為本創作之實施示意圖(四)~(七),並搭配參閱「圖1」,在為一群體的週期性食用之減重組合物的包裝袋1中,起初僅有溶脹劑包裝袋11(圖中編號(1))之易撕口A裸露,當溶脹劑包裝袋11沿易撕線B被撕除後,水溶性纖維素包裝袋12_1(圖中編號(2))之易撕口A將裸露,且再將水溶性纖維素包裝袋12_1撕除後,水溶性纖維素包裝袋12_2(圖中編號(3))之易撕口A亦將裸露,並可依此步驟逐步將水溶性纖維素包裝袋12_1、水溶性纖維素包裝袋12_2、水溶性纖維素包裝袋12_3(圖中編號(4))、水溶性纖維素包裝袋12_4(圖中編號(5))給撕除,使用者即可簡單由裸露的易撕口A判斷週期性食用之減重組合物的包裝袋1內溶脹劑包裝袋11、及水溶性纖維素包裝袋12的使用順序,有效降低使用阻力及提升使用體驗;
此外,本創作之實施示意圖僅示例其中一種溶脹劑包裝袋11、及水溶性纖維素包裝袋12的排列方式,但不以此為限,但凡可完成上述特徵者皆可實施,特此澄明。
Please refer to "Fig. 6" ~ "Fig. 9" for the schematic diagrams (4) to (7) of the implementation of this creation, and refer to "Fig. 1" in conjunction with "Fig. 1". In the
請參閱「圖10」,圖10為本創作之另一實施例,如圖所示,本創作之溶脹劑包裝袋11、及水溶性纖維素包裝袋12更具有一時間提示標示T,時間提示標示T係備註了溶脹劑包裝袋11、及水溶性纖維素包裝袋12建議的使用時間,可例如為:「早餐」、「早餐前」、「早餐後」、「起床後」、「上午八點」等各時間點提示,以上僅為示例,不以此為限;此外,時間提示標示T更可為一使用順序標記,使用順序標記係標示了週期性食用之減重組合物的包裝袋1提醒的使用次序,係可幫助使用者了解週期性食用之減重組合物的包裝袋1的拆解順序,得到更佳的使用體驗。
Please refer to "Fig. 10". Fig. 10 is another embodiment of the creation. As shown in the figure, the swelling
請參閱「圖11」,為持續使用本創作之時間與體重變化的關係圖(一),其中,橫軸為時間,縱軸為體重變化,且關係圖中記錄為日期與每日體重變化之折線圖,如圖所示,使用者為五十四歲男性,在使用本創作前為90公斤,隨著使用時間,體重呈現穩定下降趨勢,並於使用兩個月後,體重約減輕9-10公斤,確實具有明顯減重效果。 Please refer to "Figure 11", which is a graph (1) of the relationship between time and weight change during continuous use of this creation, in which the horizontal axis is time and the vertical axis is weight change, and the relationship between date and daily weight change is recorded in the graph. The line chart, as shown in the picture, the user is a 54-year-old male. Before using this creation, the weight was 90 kg. With the use of time, the weight showed a steady downward trend, and after two months of use, the weight decreased by about 9- 10 kg, does have a significant weight loss effect.
請參閱「圖12」,為持續使用本創作之時間與體重變化的關係圖(二),其中,橫軸為時間,縱軸為體重變化, 且關係圖中記錄為日期與每日體重變化之折線圖,如圖所示,使用者為六十四歲、並持續服用糖尿病藥物五年以上之女性,在使用本創作前為74公斤,於使用兩個月後,體重約減輕6公斤,足以佐證對於患有糖尿病疾病之患者,亦可使用本創作,且確實具有明顯減重效果。 Please refer to "Figure 12", which is a graph (2) of the relationship between time and weight change during continuous use of this creation. The horizontal axis is time, and the vertical axis is weight change. And the relationship chart is recorded as a line chart of dates and daily weight changes. As shown in the figure, the user is a 64-year-old woman who has been taking diabetes drugs for more than five years. Before using this creation, it was 74 kg. After two months of use, the body weight was reduced by about 6 kg, which is enough to prove that patients with diabetes can also use this creation, and it does have a significant weight loss effect.
由上所述可知,本創作之週期性食用之減重組合物的包裝袋,主要包含有一溶脹劑包裝袋、一水溶性纖維素包裝袋、及一組合件,由組合件將溶脹劑包裝袋、及水溶性纖維素包裝袋打包為一群體,如此輔助使用者能簡單的按照建議規則使用;另外,更成型有易撕口及易撕線,將易撕口位置成型在易撕線撕除的周緣,且各易撕線僅成型有唯一的易撕口,如此可引導使用者依照建議方法進行使用;此外,透過時間提示標示及順序標記亦可大幅降低使用阻力及帶來良好的使用體驗;據此,本創作據以實施後,確實可以達到能夠有效改善執行者的使用狀況,而能簡單的依照建議執行,並且同時降低飢餓感,又不需承受前述減重藥物的副作用,讓減重執行者能夠更順利的減少進食、斷食、甚至改善便秘的問題之目的。 From the above, it can be seen that the packaging bag of the periodic edible weight-reducing composition mainly includes a swelling agent packaging bag, a water-soluble cellulose packaging bag, and an assembly, and the swelling agent packaging bag is formed by the assembly. , and water-soluble cellulose packaging bags are packaged into a group, so that users can easily use according to the recommended rules; in addition, there are easy-tear openings and easy-tear lines, and the easy-tear openings are formed on the easy-tear lines to tear off. and each tearing line is formed with a unique tearing opening, which can guide users to use according to the recommended method; in addition, the time prompt mark and sequence mark can also greatly reduce the use resistance and bring a good user experience ;Accordingly, after this creation is implemented, it can indeed effectively improve the use status of the performers, and can simply follow the recommendations, and at the same time reduce hunger, and do not need to suffer the side effects of the aforementioned weight loss drugs. Heavy performers can more smoothly reduce eating, fasting, and even improve the problem of constipation.
唯,以上所述者,僅為本創作之較佳之實施例而已,並非用以限定本創作實施之範圍;任何熟習此技藝者,在不脫離本創作之精神與範圍下所作之均等變化與修飾,皆應涵蓋於本創作之專利範圍內。 However, the above descriptions are only preferred embodiments of this creation, and are not intended to limit the scope of implementation of this creation; anyone who is familiar with this technique can make equal changes and modifications without departing from the spirit and scope of this creation. , shall be covered by the patent scope of this creation.
綜上所述,本創作係具有「產業利用性」、「新穎性」與「進步性」等專利要件;申請人爰依專利法之規定,向 鈞局提起新型專利之申請。 To sum up, this creation has the patent requirements of "industrial applicability", "novelty" and "progressiveness"; the applicant should file an application for a new type patent with the Jun Bureau in accordance with the provisions of the Patent Law.
1:週期性食用之減重組合物的包裝袋 1: Packaging bag of the weight loss composition for periodic consumption
11:溶脹劑包裝袋 11: Swelling agent packaging bag
12:水溶性纖維素包裝袋 12: Water-soluble cellulose packaging bag
13:組合件 13: Assembly
F:溶脹劑 F: swelling agent
C:水溶性纖維素 C: water-soluble cellulose
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW111200619U TWM628606U (en) | 2022-01-17 | 2022-01-17 | Packaging bag of weight loss composition for periodic consumption |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW111200619U TWM628606U (en) | 2022-01-17 | 2022-01-17 | Packaging bag of weight loss composition for periodic consumption |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TWM628606U true TWM628606U (en) | 2022-06-21 |
Family
ID=83063558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW111200619U TWM628606U (en) | 2022-01-17 | 2022-01-17 | Packaging bag of weight loss composition for periodic consumption |
Country Status (1)
| Country | Link |
|---|---|
| TW (1) | TWM628606U (en) |
-
2022
- 2022-01-17 TW TW111200619U patent/TWM628606U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100256147B1 (en) | Oral disintegrating preparations and preparation method thereof | |
| US20050205083A1 (en) | Medicament storage and delivery devices | |
| US9271938B2 (en) | Sustained release beads and suspensions including the same for sustained delivery of active ingredients | |
| JPH09506268A (en) | Method for labeling rapidly dissolving dosage forms | |
| RU2002106748A (en) | Tramadol Pharmaceutical Salts | |
| WO2015003478A2 (en) | Orally disintegrating pill for infants and children and preparation method therefor | |
| CN104352471A (en) | Fluvoxamine maleate sustained release tablets and preparation method thereof | |
| CN101732342A (en) | Oral rehydration salt effervescent tablet and application thereof | |
| Roe | Drug-nutrient interactions in the elderly | |
| TWM628606U (en) | Packaging bag of weight loss composition for periodic consumption | |
| US20200383903A1 (en) | Supplements composition with effervescent agent | |
| JPH04193823A (en) | Pill readily crushable with teeth and easily administrable without water | |
| CN1384104A (en) | Methods, kits and compositions using pyrrole derivatives | |
| JP2015164945A (en) | Pharmaceutical composition comprising loxoprofen | |
| JP5796942B2 (en) | Loxoprofen-containing pharmaceutical composition | |
| JP5681430B2 (en) | Loxoprofen-containing pharmaceutical composition | |
| RU2440126C2 (en) | Oral systemic drug delivery system | |
| JP3241013U (en) | Package for filling composite water-soluble gel containing active ingredients | |
| CN208037164U (en) | Portable medicine taking auxiliary reagent box | |
| CN213346933U (en) | Tea-seed oil soft capsule convenient to tear | |
| JP6145143B2 (en) | Pharmaceutical preparation containing cycloalkane derivative or salt thereof | |
| Gangwar et al. | Development and Evaluation of Biodegradable Floating Drug Delivery for Solubility Enhancement of Diclofenac Sodium | |
| US20220160619A1 (en) | Effervescent Drug Formulations | |
| KR20100134156A (en) | Cure for bloat. | |
| TWM451972U (en) | Functional double-layer tablet |